Sequential hemi-body radiotherapy in advanced multiple myeloma

Area of Science:

• Oncology
• Radiation Oncology
• Hematology

Background:

• Advanced multiple myeloma is a hematologic malignancy with limited treatment options for refractory cases.
• Skeletal pain and tumor burden are significant challenges in managing advanced multiple myeloma.

Purpose of the Study:

• To evaluate the efficacy and safety of sequential hemi-body radiotherapy in patients with advanced multiple myeloma resistant to chemotherapy.
• To assess pain relief, objective tumor response, and treatment-related morbidity.

Main Methods:

• Eleven patients with advanced multiple myeloma received sequential hemi-body radiotherapy (800 rad midplane, single dose to each half).
• Patients were monitored for pain relief, objective tumor response, and adverse events.

Main Results:

• 9 out of 10 patients achieved significant relief of skeletal pain.
• 5 out of 11 patients showed objective tumor responses, including one complete remission.
• Treatment-related morbidities were notable, including nausea, emesis, bone marrow suppression, and pneumonitis.

Conclusions:

• Sequential hemi-body radiotherapy demonstrates potential benefit in managing advanced multiple myeloma, particularly for skeletal pain.
• The observed morbidities suggest careful patient selection and monitoring are necessary.
• Investigating this radiotherapy regimen earlier in the disease course may improve outcomes.